Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Market Cap
$30.97M
EBITDA Margin
-76.51%
TTM Avg
-510.64%
3Y Avg
-659.38%
5Y Avg
-619.37%
Market Cap
$29.65M
EBITDA Margin
-2671.72%
TTM Avg
-3785.12%
3Y Avg
-14400.08%
5Y Avg
-14400.08%
Market Cap
$31.12M
EBITDA Margin
-5.74%
TTM Avg
-12.14%
3Y Avg
-35.62%
5Y Avg
-63.06%
Market Cap
$30.00M
EBITDA Margin
-10097.04%
TTM Avg
-6618.17%
3Y Avg
-8743.58%
5Y Avg
-8072.84%
Market Cap
$29.95M
EBITDA Margin
-17954.61%
TTM Avg
-17954.61%
3Y Avg
-17954.61%
5Y Avg
-17954.61%
Market Cap
$31.44M
EBITDA Margin
2.14%
TTM Avg
1.67%
3Y Avg
3.35%
5Y Avg
2.87%
Market Cap
$29.48M
EBITDA Margin
-2299.40%
TTM Avg
-2138.43%
3Y Avg
-3018.63%
5Y Avg
-2749.35%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MIRA Pharmaceuticals, Inc. (MIRA) | $30.69M | N/A | N/A | N/A | N/A |
| SCYNEXIS, Inc. (SCYX)vs › | $30.97M | -76.51% | -510.64% | -659.38% | -619.37% |
| BeyondSpring Inc. (BYSI)vs › | $29.65M | -2671.72% | -3785.12% | -14400.08% | -14400.08% |
| MDxHealth S.A. (MDXH)vs › | $31.12M | -5.74% | -12.14% | -35.62% | -63.06% |
| CervoMed Inc. (CRVO)vs › | $30.00M | -10097.04% | -6618.17% | -8743.58% | -8072.84% |
| GridAI Technologies Corp. (GRDX)vs › | $29.95M | -17954.61% | -17954.61% | -17954.61% | -17954.61% |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 2.14% | 1.67% | 3.35% | 2.87% |
| Context Therapeutics Inc. (CNTX)vs › | $29.54M | N/A | N/A | N/A | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.48M | -2299.40% | -2138.43% | -3018.63% | -2749.35% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.14M | -108.41% | -31.49% | 5.24% | 21.14% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
